A prospective randomised controlled trial to determine the nature of the immunostimulants in autologous salvaged blood

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN64731819

Enrollment

Registered

2004-09-30

Start date

2004-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Autologous salvage transfusion Surgery

Interventions

Randomised into three groups according to the type of postoperative autogous salvage transfusion.

Eligibility

Inclusion criteria

Inclusion criteria: 60 patients undergoing total knee arthroplasty at Avon Orthopaedic Centre randomised into three groups according to type of post-operative autologous salvage transfusion.

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
In vitro measures of immune status including changes in cytokine profiles and populations of certain lymphocyte subsets in whole blood.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026